COVID-19: Difference between revisions
| Line 13: | Line 13: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*[[Influenza]] | |||
*[[Pneumonia]] | |||
*[[Sinusitis]] | |||
==Evaluation== | ==Evaluation== | ||
| Line 19: | Line 21: | ||
==Management== | ==Management== | ||
*Supportive care is mainstay of therapy | |||
*Most patients will do well enough for discharge home | |||
*Discuss with LA Dept of Public Health, who will guide testing and, if discharging, help patient remain in isolation at home | |||
==Disposition== | ==Disposition== | ||
*Usually home, but decision needs to be made in conjunction with LA Dept. of Public Health | |||
*If admitting, needs to be placed in negative pressure isolation room with airborne and droplet precautions | |||
==See Also== | ==See Also== | ||
Revision as of 22:27, 16 February 2020
Background
- Also known as "2019 Novel Coronavirus"
- First detected in Wuhan, China
Clinical Features
Case definition (Jan, 2020)
- Patients with (must have ALL 3 criteria):
- Travel to Wuhan China is past 14 days OR Exposure to Known Corona Virus Patient AND
- Fever AND
- Lower respiratory symptoms (cough or shortness of breath)
Differential Diagnosis
Evaluation
- BIOFIRE RESP PANEL Corona Virus assay does NOT detect this subtype - DO NOT USE
Management
- Supportive care is mainstay of therapy
- Most patients will do well enough for discharge home
- Discuss with LA Dept of Public Health, who will guide testing and, if discharging, help patient remain in isolation at home
Disposition
- Usually home, but decision needs to be made in conjunction with LA Dept. of Public Health
- If admitting, needs to be placed in negative pressure isolation room with airborne and droplet precautions
See Also
External Links
- [[1]]